Nov 5, 2026
Acumen Pharmaceuticals, Inc. layoff.
8-K Item 2.05 filed 2026-11-05: In connection with these decisions, on November 1, 2026, the board of directors of the Company (the “Board”) approved certain steps to implement cash conservation measures, including a reduction of the Company’s workforce by 52 full-time em
For the people in it
The day after.
Your rights in this state
The federal WARN Act covers employers with 100 or more full-time workers. It requires 60 days' written notice before a plant closing that affects 50 or more workers at one site, or a mass layoff of 500 or more workers (or 50 to 499 when that is at least a third of the site).
Federal WARN (100+ employees, 60 days' notice) is the only rule we can confirm for this state.
This is an editorial summary, not legal advice.
- WARN filed
- —
- Notice date
- —
- Separation date
- —
- Notice given
- —
The package, as reported
- Severance base
- —
- Per year of service
- —
- Benefits continued
- —
- Equity
- —
- Outplacement
- —
How it was done
- Delivery
- —
- Timing
- —
- Roles affected
- —
If you were in this cohort.
- 01
File for unemployment the week you're separated — not when the severance runs out.
- 02
Check your notice date against the 60-day federal WARN rule.
- 03
Find out whether your COBRA window starts when benefits end or on your separation date.
Pack Finder
No public room for Acumen Pharmaceuticals, Inc. yet.
A Job Search Council is always open: four to six peers at your career stage, free and volunteer-run.
Evidence
SEC filing · Form 8-K · Nov 5, 2026 · SEC accession 0001628280-26-070987
“In connection with these decisions, on November 1, 2026, the board of directors of the Company (the “Board”) approved certain steps to implement cash conservation measures, including a reduction of the Company’s workforce by 52 full-time employees, or approximately 90% of the Company’s current employee base (the “Restructuring”). The Company initiated the Restructuring on November 2, 2026, with the majority of impacted positions ending in November 2026 and a small number of positions maintained into early 2027. As a result of the Restructuring, the Company estimates that it will incur approximately $7.75 million in costs resulting from cash expenditures consisting of one-time severance payme”
SEC Form 8-K, Item 2.05 ↗
Sources for this event: sec_8k, SEC Form 8-K, Item 2.05. All Acumen Pharmaceuticals, Inc. records · Report a correction
Cite this
According to Tracked by PinkSlipped, …
Source: Tracked by PinkSlipped (gotpinkslipped.com/noticed/tracked/event/acumen-pharmaceuticals-inc-2026-11-05)
By the PinkSlipped teamUpdated